A new era for clinical trials supply compliance in the EU is almost here.
Simon Jones
Advertisement
Articles by Simon Jones
Simon Jones and Gordan Alexander, both of Prisym ID, explore the added complexity to the labeling of trial supplies that new regulations to EU 536/2014 will bring, specifically Annex VI.
Advertisement
Latest Updated Articles
- Labeling Challenges from EU Annex VI
Published: September 6th 2019 | Updated:
- Labeling Challenges From EU Annex VI
Published: December 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
